These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9777315

  • 1. Milnacipran. A review of its use in depression.
    Spencer CM, Wilde MI.
    Drugs; 1998 Sep; 56(3):405-27. PubMed ID: 9777315
    [Abstract] [Full Text] [Related]

  • 2. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH, Goa KL.
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [Abstract] [Full Text] [Related]

  • 3. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
    Leinonen E, Lepola U, Koponen H, Mehtonen OP, Rimon R.
    Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
    [Abstract] [Full Text] [Related]

  • 4. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J, Guelfi JD, Pletan Y, Tournoux A, Prost JF.
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [Abstract] [Full Text] [Related]

  • 5. Clinical utility of milnacipran in comparison with other antidepressants.
    Bisserbe JC.
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S43-50. PubMed ID: 12369610
    [Abstract] [Full Text] [Related]

  • 6. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability.
    Puech A, Montgomery SA, Prost JF, Solles A, Briley M.
    Int Clin Psychopharmacol; 1997 Mar; 12(2):99-108. PubMed ID: 9219045
    [Abstract] [Full Text] [Related]

  • 7. Japanese experience with dual-action antidepressants.
    Tajima O.
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-42. PubMed ID: 12369609
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
    Kasper S, Pletan Y, Solles A, Tournoux A.
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
    [Abstract] [Full Text] [Related]

  • 14. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
    Fawcett J, Barkin RL.
    J Affect Disord; 1998 Dec; 51(3):267-85. PubMed ID: 10333982
    [Abstract] [Full Text] [Related]

  • 15. Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.
    Davis R, Whittington R, Bryson HM.
    Drugs; 1997 Apr; 53(4):608-36. PubMed ID: 9098663
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness.
    Wilde MI, Plosker GL, Benfield P.
    Drugs; 1993 Nov; 46(5):895-924. PubMed ID: 7507038
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of milnacipran and imipramine in the treatment of major depressive disorder.
    Lopez-Ibor JJ, Conesa A, Spanish Milnacipran/Imipramine Study.
    Curr Med Res Opin; 2004 Jun; 20(6):855-60. PubMed ID: 15200743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.